Matrix metalloproteinases of human leiomyoma in various stages of tumor growth

Gynecologic and Obstetric Investigation

Volumn 58, Issue 1, 2004, Pages 14-18

  Wolańska, Małgorzata ^a   Sobolewski, Krzysztof ^a   Bańkowski, Edward ^a   Jaworski, Stefan ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Leiomyoma; Matrix metalloproteinases; Myometrium

Indexed keywords

GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; STROMELYSIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; LEIOMYOMA; MYOMETRIUM; PRIORITY JOURNAL; TUMOR GROWTH; UTERUS;

ADULT; FEMALE; HUMANS; LEIOMYOMA; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MYOMETRIUM; NEOPLASM STAGING; UTERINE NEOPLASMS;

EID: 4344675173     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077177     Document Type: Article

References (29)

1. Adams JC, Watt FM: Regulation of development and differentiation by the extracellular matrix. Development 1993;117:1183-1198.
2. Aumailley M, Gayraud B: Structure and biological activity of the extracellular matrix. J Mol Med 1998;76:253-265.
3. Brandon DD, Erickson TE, Keenan EJ, Strawn Clinton GM: Estrogen EY, Novy MJ, Burry KA, Warner C: Receptor gene expression in human uterine leiomyomata. J Clin Endocrinol Metab 1995;80:1876-1881.
4. Cramer M, Pastel F: The frequency of uterine leiomyomas. Am J Clin Pathol 1990;94:435-438.
5. Marshall LM, Spiegelman D, Barbieri RL: Variation in the incidence of uterine leiomyomata among premenopausal women by age and race. Obstet Gynecol 1997;90:967-973.
6. Wolańska M, Sobolewski K, Drozdzewicz M, Bańkowski E: Extracellular matrix components in uterine leiomyoma and their alteration during the tumour growth. Mol Cell Biochem 1998;189:145-152.
7. Dioszegi M, Cannon P, Van Wart HE: Vertebrate collagenases. Methods Enzymol 1995;248:413-431.
8. Matrisian LM: The matrix-degrading metalloproteinases. Bioessays 1992;14:455-463.
9. Parsons SL, Watson SA, Brown PD, Collins HM, Steele RC: Matrix metalloproteinases. Br J Surg 1997;84:160-166.
10. Unemori EN, Werb Z: Reorganization of polymerized actin: A possible tiger for induction of procollagenase in fibroblasts cultured in and on collagen gels. J Cell Biol 1986;103:1021-1031.
11. Woessner JF Jr: Matrix metalloproteinases and their inhibitors in connective tissues remodelling. FASEB J 1991;5:2145-2154.
12. Forget MA, Desrosiers RR, Beliveau R: Physiological roles of matrix metalloproteinases: Implications for tumor growth and metastasis. Can J Physiol Pharmacol 1999;77:465-480.
13. Palmer SS, Hayns-Johnson D, Diehl T, Nowak RA: Increased expression of stromelysin 3 mRNA in leiomyomas (uterine fibroids) compared with myometrium. J Soc Gynecol Invest 1998;5:203-209.
14. Salamonsen LA: Matrix metalloproteinases and endometrial remodelling. Cell Biol Int 1994;18:1139-1144.
15. Dou Q, Tarnuzzer RW, Williams RS, Schultz GS, Chegini N: Differential expression of matrix metalloproteinases and their tissue inhibitors in leiomyomata: A mechanism for gonadotrophin releasing hormone agonist-induced tumour regression. Mol Hum Reprod 1997;3:1005-1014.
16. Ma C, Chegini N: Regulation of matrix metalloproteinases (MMPs) and their tissue inhibitors in human myometrial smooth muscle cells by TGF-beta1. Mol Hum Reprod 1999;5:950-954.
17. Curran S, Murray GI: Matrix metalloproteinases in tumour invasion and metastasis. J Pathol 1999;189:300-308.
18. Iozzo RV: Matrix proteoglycans: From molecular design to cellular function. Annu Rev Biochem 1998;67:609-652.
19. Jackson RL, Busch SJ, Cardin AD: Glycosaminoglycans: Molecular properties, protein interaction, and role in physiological processes. Physiol Rev 1991;71:481-525.
20. Taipale J, Keski-Oja J: Growth factors in the extracellular matrix. FASEB J 1997;11:51-59.
21. Senior RM, Griffin GL, Fliszar CJ, Shapiro SD, Goldberg GI, Welgus HG: Human 92- and 72-kilodalton type IV collagenase are elastases. J Biol Chem 1991;266:7870-7875.
22. Wu JJ, Lark MW, Chun LE, Eyre DR: Sites of stromelysin cleavage in collagen types II, IX, X, XI of cartilage. J Biol Chem 1991;266:5625-5628.
23. Kielty CM, Hopkinson I, Grant ME: The collagen family: Structure, assembly and organisation; in Royce PM, Steinman B (eds): Connective Tissue and Heritable Disorders. New York, Wiley-Liss 1993, pp 103-147.
24. Murphy G, Crabbe T: Gelatinases A and B. Methods Enzymol 1995;248:470-484.
25. Birkedal-Hansen H, Taylor RE: Detergent-activation of latent collagenase and resolution of its component molecules. Biochem Biophys Res Commun 1982;107:1173-1178.
26. John A, Tuszynski G: The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res 2001;7:14-23.
27. Giannelli G, Antonaci S: Gelatinases and their inhibitors in tumor metastasis: From biological research to medical applications. Histol Histopathol 2002;17:339-345.
28. Coussens LM, Werb Z: Matrix metalloproteinases and the development of cancer. Chem Biol 1996;3:895-904.
29. Zeng ZS, Huang Y, Cohen AN, Guillem JG: Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9. J Clin Oncol 1996;14:3133-3140.